Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9615 posts found.

eisa0008

Eisai reveals new long-term seizure control data at ECE 2016

September 13, 2016 Manufacturing and Production, Research and Development Eisai, epilepsy

Eisai has revealed new data on long-term seizure control in different seizure types at the 12th European Congress on Epileptology …
News
web_scientist-filling-out-form---credit-national-institutes-of-health

Proteomics market to grow to $24.8 billion by 2024

September 13, 2016 Manufacturing and Production, Research and Development Grand View Research, proteomics

The global proteomics market is predicted to grow to exceed $24.8 billion by 2024, according to a new report by …
News
takeda_world

Takeda forms “first of its kind” developmental partnership with CRO

September 13, 2016 Manufacturing and Production, Research and Development PRA Health Services, Takeda, partnership

Takeda and PRA Health Services have announced a new partnership that will see the Japanese pharma giant transfer 300 staffers …
News

New Sanofi/Alphabet partnership names CEO

September 12, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, appointment, google

As part of the news that French drugmaker Sanofi and Google parent Alphabet’s life sciences firm Verily are to join …
Appointment
als_ely_facility

ALS Pharma quadruples Cambridgeshire testing facility in £2m expansion

September 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ALS Pharmaceutical, Microbiology, expansion

UK microbiology and chemical analysis company ALS Pharmaceutical has quadrupled the size of its facility in Ely, Cambridgeshire as part …
News
google

Sanofi and Google forge $500 million diabetes partnership

September 12, 2016 Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, diabetes, google

Sanofi is set to join forces with Alphabet’s life sciences firm Verily in a $500 million partnership to develop diabetes …
News
afd-69766

Gilead appoints former Roche executive

September 9, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Roche, appointment

Gilead Sciences has hired Rogers Luo as vice president and general manager of commercial operations in China. Luo formerly served …
Appointment
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

Kymab demonstrates promising research for HIV vaccine development

September 9, 2016 Medical Communications, Research and Development HIV, Vaccine, kymab

Cambridge-based antibodies-to-medicines company Kymab has announced publication of research testing the first step in the effort to develop effective vaccines …
News
gsk-house-location-building

GSK proposes biopreparedness unit to combat global outbreaks

September 9, 2016 Medical Communications, Research and Development Ebola, GSK, Zika

London-based pharma giant GlaxoSmithKline has proposed the creation of a biopreparedness unit to help avert crises like those we have …
News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

September 9, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, BMS, Celgene, Cloud Computing, Eisai, FDA, GSK, Halaven, Novartis, Novo Nordisk, Roche, Teva, agios, epipen, rheumatoid arthritis

It’s Friday, and that means it’s time for another run-down of the biggest stories on Pharmafile.com over the last week. …
News

Apple introduce stricter entry requirements for health apps

September 8, 2016 Medical Communications, Research and Development Apple, Guidelines, apps, iphone, strict

Apple has toughened its stance on health and medical apps that can be bought and downloaded on the iOS App …
News
dollars_medicines

Retrophin announces positive Phase II results, Shkreli claims credit

September 8, 2016 Research and Development Phase II, Retrophin, Shkreli, rare kidney disease

Retrophin has announced positive top-line results for trial drug sparsentan in Phase II to treat a rare kidney disorder with …
News
celgene_1_02

Celgene and Agios to file FDA application for “first-in-class” cancer drug

September 8, 2016 Research and Development, Sales and Marketing Celgene, FDA, NDA, acute myeloid leukaemia, agios

According to an SEC 8-K filing by Agios, the company and its partner Celgene intend to file a new drug …
News
takeda_tokyo_hq

Takeda begins Phase III dengue vaccine trial

September 8, 2016 Research and Development Takeda, Vaccine, dengue, dengue vaccine, phase III, trial

Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …
News
c_ssilver-fotolia_ebr_jul_2014

Clinical Trial Transparency

September 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trial, clinical trial transparency, transparency

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …
Feature
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026